Initial studies in CRC have identified nearly 20 individual aberrantly expressed lncRNAs, many of which function as oncogenes or tumor suppressors by participating in critical signaling pathways such as MYC, WNT, and TP53 [18]. This evidence concerns the gene TP53 and colorectal carcinoma.